Akso Health vs Cryo Cell International
Cryo Cell International is the larger business, with $31.6m of revenue in fiscal 2025 against $13.8m for Akso Health (2.3 times as much). Cryo Cell International grew faster (-1.3% against -6.4%). Cryo Cell International kept more of each dollar of sales as profit: a net margin of -7.7% against -135.0%.
| Latest fiscal year | Akso HealthAHG, 2026 | Cryo Cell InternationalCCEL, 2025 |
|---|---|---|
| Revenue | $13.8m | $31.6m |
| Revenue growth | -6.4% | -1.3% |
| Net income | −$18.7m | −$2.4m |
| Operating margin | — | 1.5% |
| Net margin | -135.0% | -7.7% |
| Return on equity | -9.8% | — |
| Free cash flow | −$12.8m | $5.2m |
| Cash | $170,572 | $319,031 |
| Total debt | $0 | $10.7m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | 0.0% |
| Share buybacks | — | $169,502 |
| Employees | — | 72 |
| Market value | $860m | $40.7m |
| Price vs our value range | — | Below our value range |
| Moat score | — | 73 (Strong) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |